PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 2172233
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 2172233
Medical Implants market size was valued at US$ 106,317.5 Million in 2025, expanding at a CAGR of 6.6% from 2026 to 2033.
Medical Implants refer to surgical devices that have been designed to improve the function of body parts. Medical Implants vary depending on the body parts they are designed for-orthopedic implants, cardiac implants, dental implants, neurostimulator implants, and many more in the product line. Advanced technology is involved in the production of these products using techniques such as 3D printing and prototyping. In addition, the incorporation of materials such as titanium, ceramic, and polymers during production increases the safety of the product since the body accepts them easily. Some of the main factors that are contributing to the growth of the market include chronic diseases, aging population, and minimally invasive procedures. In conclusion, medical implants meet the growing demand for healthcare while supporting the body's functionality.
Medical Implants Market- Market Dynamics
Growing Prevalence of Chronic Conditions to Accelerate Market Growth
The growing prevalence of chronic conditions and the need for medical implants for the restoration of lost body functions and replacement of organs and tissue have come up. For instance, in May 2026, according to the Commonwealth Fund's International Health Care System Profiles: Japan, the number of deaths caused by noncommunicable diseases in Japan amounted to 85.3%. In addition, people aged 65 years and above, who make up 29% of the total population, spent 62% of the national healthcare budget. Furthermore, the Japanese population aged 65 years and above is increasing, leading to the requirement of services related to dementia and long-term care. These figures highlight the growing pressure of chronic and age-related conditions on Japan's health care system.
The Global Medical Implants market is segmented on the basis of Product, Material, Technology, End User, and Region.
Among the given product types, orthopedic implants are expected to hold a prominent share in the Medical Implants market because of their growing use in joint and fracture surgeries as well as in musculoskeletal diseases. In October 2025, according to the American Academy of Orthopaedic Surgeons (Org), there was a review of more than 4.4 million cases of hip and knee arthroplasties performed in the US. The registry reviewed the cases from all 50 states, Washington, DC, and Puerto Rico. This is an 8.8 percent increase from last year. In addition, the registry has more than 4.6 million cases in total, indicating the growing trend in joint replacement and orthopedic implants. Thus, increasing joint replacements and musculoskeletal disorders drive the major market share of orthopedic implants.
Under technology, conventional implants hold a notable share in the Medical Implants market due to their clinical proven success and reliability as well as wide application in medical procedures. In September 2025, BIOTRONIK introduced the Solia CSP S pacing lead using the fixed screw technology along with a stylet-guided implantation method for performing the conduction system pacing operation. Therefore, although traditional implants dominate the market, it is innovation that drives precision in medical operations.
Medical Implants Market- Geographical Insights
North America is expected to maintain strong market growth due to an increase in the number of surgeries performed, development in technologies used in the industry, and increasing numbers of elderly people. For instance, in June 2025, according to the Peter G. Peterson Foundation Org., the United States was ranked 1st in the index of scientific advancements and dominated other countries in the number of newly developed and approved by regulators drugs and devices. The index includes 13 factors in the analysis of the health care system through 37 metrics, such as the development and scientific impact. These findings highlight the role of medical technology innovation in advancing healthcare capabilities in the United States.
The global market for medical implants has a partially consolidated competitive environment, and some of its major players include Dentsply Sirona Inc., Cochlear Limited, Smith & Nephew plc, Globus Medical, Inc., and B. Braun SE. Each of these companies invests in researching and developing new products and forming strategic alliances to expand their medical implants line-up and to outshine their competition. In January 2026, Dentsply Sirona signed an extended partnership deal with Benco Dental. The company also sells the manufacturer's connected dental technology products like CEREC systems and materials around the globe. Thus, to sum up, it can be said that strategic partnerships and product development have proven to be crucial for establishing a competitive advantage within the market of medical implants.
In January 2026, Smith+Nephew acquired Integrity Orthopaedics to increase its offerings in the domain of sports medicine using the Tendon Seam rotator cuff repair technology based on microanchors, continuous sutures, and multi-point attachment for repairing the rotator cuffs. It is expected to add value to Smith+Nephew's suite of REGENETEN bioinductive implants.
In July 2025, Cochlear Limited received the FDA approval for its Nucleus Nexa smart cochlear implant system that consists of upgradable firmware of the implant with an internal memory to save hearing settings of the patients. The company has created a new technology platform for future software updates without replacing the implant.